QNCX

QNCX

USD

Quince Therapeutics Inc. Common Stock

$1.600+0.040 (2.564%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.560

Hoch

$1.620

Tief

$1.555

Volumen

0.11M

Unternehmensfundamentaldaten

Marktkapitalisierung

85.9M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.27M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $0.72Aktuell $1.600Hoch $2.45

Ähnliche Nachrichten

BusinessWire

Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting

Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced the poster presentation of

Mehr anzeigen
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting
Analyst Upgrades

D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $4 Price Target

D. Boral Capital analyst Jason Kolbert maintains Quince Therapeutics with a Buy and maintains $4 price target.

Mehr anzeigen
D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $4 Price Target
BusinessWire

Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study

Quince Therapeutics, Inc.

Mehr anzeigen
Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study